Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Condroflex
São José da Lapa, Minas Gerais, Brazillaboratorioglobo.com.br ↗
- Ownership
- Private
- Employees
- ~500
- Development stage
- Other
01
Overview
Laboratório Globo is a Brazilian pharmaceutical company that develops, manufactures, and markets a wide range of generic and branded medications. One of its most prominent products is Condroflex, a widely used treatment for osteoarthritis and joint degeneration containing glucosamine and chondroitin. The company operates a significant manufacturing facility in Minas Gerais and focuses on providing affordable healthcare solutions across various therapeutic areas, including orthopedics, cardiology, and infectious diseases. Laboratório Globo is a key player in the Brazilian retail pharma market, maintaining a robust distribution network for its diverse portfolio of over 200 products.
- Therapeutic areas
- Rheumatology
- Modalities
- Small moleculePeptides
- Industry
- Biotech
Beyond the preview
Go deeper on Condroflex.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Condroflex.